All stock lists
TriSalus Life Sciences, Inc. (NASDAQ:TLSI)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
3.63+0.04 (+1.11%)
Insider Score
––Not scored
TLSI Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
TLSI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 11.41 M | 8.90 M | 13.21 M | 11.57 M | 11.21 M | 9.17 M |
| Revenue Growth (YoY) | 1.73 % | -2.92 % | 59.85 % | 57.38 % | 52.27 % | 41.97 % |
| Cost of Revenue | 1.51 M | 1.23 M | 1.76 M | 1.91 M | 1.80 M | 1.50 M |
| Gross Profit | 9.90 M | 7.67 M | 11.44 M | 9.66 M | 9.41 M | 7.67 M |
| SG&A Expense | 16.57 M | 12.86 M | 12.14 M | 13.50 M | 12.82 M | 11.71 M |
| R&D Expense | 3.14 M | 3.22 M | 2.57 M | 5.18 M | 3.92 M | 3.30 M |
| Operating Expenses | 19.71 M | 16.08 M | 14.71 M | 18.67 M | 16.74 M | 15.00 M |
| Operating Income | -9.81 M | -8.41 M | -3.27 M | -9.01 M | -7.33 M | -7.33 M |
| Pretax Income | -9.18 M | 1.54 M | -9.75 M | -10.81 M | -8.29 M | -10.37 M |
| Tax Provision | 4.00 K | 4.00 K | 0.00 | 5.00 K | -3.00 K | 5.00 K |
| Net Income | -9.19 M | 1.54 M | -9.75 M | -10.81 M | -8.29 M | -10.38 M |
| EPS (Basic) | -0.16 | 0.03 | -0.21 | -0.96 | -0.27 | -0.39 |
| EPS (Diluted) | -0.16 | 0.03 | -0.21 | -0.96 | -0.27 | -0.39 |
| Shares Outstanding | 58.30 M | 51.54 M | 46.84 M | 43.06 M | 32.90 M | 28.53 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.